Direktorat Registrasi ObatValid

KALFOXIM

BPOM Number: DKL8811606044C1
Approved: 21 November 2024
Expiry: 9 July 2028
Form: SERBUK INJEKSI;

About This Registration

KALFOXIM is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL8811606044C1. Its current registration status is Valid, with the licence valid until 9 July 2028. The product is registered to KALBE FARMA - INDONESIA. BPOM first approved this registration in March 2024. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 1 VIAL @ 500 MG + 1 AMPUL @ 2 ML
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

KALBE FARMA - INDONESIA
KAB. BEKASI
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

KALBE FARMA - INDONESIA
KAB. BEKASI
primary
View profile →

Ingredients (1)

CEFOTAXIME SODIUM

Market Intelligence

Owner Portfolio: KALBE FARMA - INDONESIA holds 271 BPOM registrations
Manufacturer Scale: KALBE FARMA - INDONESIA produces 271 registered products
Registration Age: Registered for 2 years, 6 months

Is this your product?